Name
and
Present
Position:
HELMUT
G.
RENNKE,
Chief,
Renal
Pathology
Address:
Brigham
and
Women's
Hospital,
Department
of
Pathology,
75
Francis
Street,
Boston,
MA
Medical
School
(including
school
name,
date
and
degree
awarded):
1971
MD,
University
of
Chile
Medical
School,
Santiago,
Chile
|
| |
Graduate
Medical Education (including dates and institution of internships, residencies,
fellowships, etc.):
1970-1971 Rotating
Internship, Hospital del Salvador, Santiago, Chile
1971-1972 Fellow in Pathology, University of Kiel, Germany
1972-1974 Resident in Pathology, Mallory Institute of Pathology, Boston,
MA
1974-1977 Resident in Pathology, Peter Bent Brigham Hospital, Boston,
MA
1974-1977 Resident and Research Fellow, Peter Bent Brigham Hospital
Certification:
1980 American Board
of Pathology (Anatomic Pathology)
Current Academic
Appointment:
Professor of Pathology,
Harvard Medical School, Boston, MA
and Harvard-MIT Division of Health Sciences and Technology at MIT/Harvard
Medical School
Current Medical
Staff Appointment:
Chief, Renal Pathology
Pathologist, Brigham and Women's Hospital
Consultant in Pathology, Boston Medical Center and Mallory Institute
of Pathology
Selected Bibliography:
- Vella JP, Magee
C, Vos L, Womer K, Rennke H, Carpenter CB, Hancock W, Sayegh MH. Cellular
and humoral mechanisms of vascularized allograft rejection induced by
indirect recognition of donor MHC allopeptides. Transplantation 1999
67:1523-32
- Laurinavicius A,
Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients:
A clinicopathological and follow-up study. Kidney Int 1999; 56: 2203-13.
- Kaplan JM, H Kim
S, North KN, Rennke H, A Correia L, Tong HQ, Mathis BJ, Rodriguez-Perez
JC, Allen PG, Beggs AH, Pollak MR. Mutations in ACTN4, encoding alpha-actinin-4,
cause familial focal segmental glomerulosclerosis. Nature Genet 2000;
24:251-6.
- Ziai F, Nagano
H, Kusaka M, Coito AJ, Troy JL, Nadeau KC, Rennke HG, Tilney NL, Brenner
BM, MacKenzie HS. Renal allograft protection with losartan in Fisher-->Lewis
rats: hemodynamics, macrophages, and cytokines. Kidney Int 2000; 57:2618-25.
- O'Bryan T, Weiher
H, Rennke HG, Kren S, Hostetter TH. Course of renal injury in the Mpv17-deficient
transgenic mouse. J Am Soc Nephrol 2000;11:1067-74
- Thurberg BL, Rennke
H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O'Callaghan
M. Globotriaosylceramide accumulation in the Fabry kidney is cleared
from multiple cell types after enzyme replacement therapy. Kidney Int
2002; 62:1933-1946.
|